Özkan Ömer, Özkan Özlenen, Ubur Mehmetcan, Hadimioğlu Necmiye, Cengiz Melike, Afşar İsmail
Department of Plastic and Reconstructive Surgery, Akdeniz University Faculty of Medicine, Antalya, Turkey.
Department of Anaesthesiology and Reanimation, Akdeniz University Faculty of Medicine, Antalya, Turkey.
Microsurgery. 2018 Nov;38(8):834-843. doi: 10.1002/micr.30272. Epub 2017 Nov 27.
The aim of this report is to present our long-term experiences with a series of 5 face-transplanted patients in terms of surgical aspects and postoperative outcomes, and to describe possible salvage strategies in case of difficulties.
Five patients, 4 receiving full-face transplantation and 1 undergoing partial transplantation at our institution were included. The patients were aged between 19 and 54 years. Two had extensive burn scars to the face, and 3 had suffered gunshot injuries. The post-transplant induction immunosuppressive regimen included ATG combined with tacrolimus, mycophenolate mofetil, and prednisone, while maintenance was provided by the last 3. We focused on patient summaries including their etiologies, preoperative preparations, surgical techniques, immunosuppressive regimen, postoperative courses, revisional surgeries, together with challenges including acute rejection episodes, and immunosuppressive drug complications.
No re-surgery due to vascular compromise was required in any case. One of the 5 patients was eventually lost due to complicated infectious and metabolic events at the end of post-transplantation month 11. The other 4 patients were still alive, with a mean follow-up time of 53 months and had satisfactory functional transplants and cosmetic appearance.
Face transplantation still involves challenges and many issues including compliance and psychological maturity of patients, the risk of opportunistic infections and malignancies still need to be resolved for it to be accepted as a safe procedure. Surgical rescue procedures considering ideal timing should be kept in mind strictly as one of the most important issues in case of unexpected events.
本报告旨在介绍我们对5例面部移植患者在手术方面和术后结果的长期经验,并描述遇到困难时可能的挽救策略。
纳入了5例患者,其中4例在我院接受全脸移植,1例接受部分移植。患者年龄在19至54岁之间。2例面部有广泛烧伤瘢痕,3例遭受枪伤。移植后的诱导免疫抑制方案包括抗胸腺细胞球蛋白联合他克莫司、霉酚酸酯和泼尼松,维持治疗则由后三种药物提供。我们重点关注患者总结,包括病因、术前准备、手术技术、免疫抑制方案、术后病程、修复手术,以及包括急性排斥反应和免疫抑制药物并发症在内的挑战。
所有病例均无需因血管并发症而再次手术。5例患者中有1例在移植后第11个月末因复杂的感染和代谢事件最终死亡。其他4例患者仍存活,平均随访时间为53个月,移植功能和外观均令人满意。
面部移植仍然面临挑战,包括患者的依从性和心理成熟度等诸多问题,机会性感染和恶性肿瘤的风险仍需解决,才能使其被视为一种安全的手术。在意外事件发生时,应严格牢记考虑理想时机的手术挽救程序是最重要的问题之一。